Articles and Information
Form 7 Monthly Progress Report January 2026
Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of
February 7, 2026
- News
Dr. Safieddin Safavi-Naeini Joins Biomark Scientific Advisory Team
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
News
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection
January 18, 2026
Articles and Information
Form 7 Monthly Progress Report December 2025
Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of
January 5, 2026
News
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors Expanding U.S. market
January 3, 2026
News
BioMark: 2025 Achievements & 2026 Vision
BioMark: 2025 Achievements & 2026 Vision Celebrating A Year of Extraordinary Achievement VANCOUVER, BRITISH COLUMBIA
January 2, 2026
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2